King-Jones Heidy
SEC insider (Form 3/4/5 filer). CIK 0001794898. Officer at Spyre Therapeutics, Inc. (SYRE). 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WALTHAM, MA.
Companies King-Jones Heidy has filed insider reports for
- Spyre Therapeutics, Inc. (SYRE): Officer, See Remarks
King-Jones Heidy
CIK: 0001794898
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Spyre Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
ExerciseDirect28.9K shares at avg. $14.50$420K - Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect16.6K shares at avg. $90.35$1.5M - Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect7.2K shares at avg. $91.35$660K - Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect2.1K shares at avg. $92.70$195K - Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect2.6K shares at avg. $93.46$243K - Oct 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect400 shares at avg. $89.24$36K - Sep 2, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect400 shares at avg. $90.00$36K - Sep 2, 2026SYRE
Spyre Therapeutics, Inc.
ExerciseDirect400 shares at avg. $14.50$6K - Sep 1, 2026SYRE
Spyre Therapeutics, Inc.
ExerciseDirect28K shares at avg. $14.50$406K - Sep 1, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect4.8K shares at avg. $86.40$419K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Exercise | 28,933 | $14.50 | $419,529 | Direct |
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 16,605 | $90.35 | $1,500,262 | Direct |
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 7,228 | $91.35 | $660,278 | Direct |
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 2,100 | $92.70 | $194,670 | Direct |
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 2,600 | $93.46 | $242,996 | Direct |
| Oct 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 400 | $89.24 | $35,696 | Direct |
| Sep 2, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 400 | $90.00 | $36,000 | Direct |
| Sep 2, 2026 | SYRE Spyre Therapeutics, Inc. | Exercise | 400 | $14.50 | $5,800 | Direct |
| Sep 1, 2026 | SYRE Spyre Therapeutics, Inc. | Exercise | 27,999 | $14.50 | $405,986 | Direct |
| Sep 1, 2026 | SYRE Spyre Therapeutics, Inc. | Sale | 4,845 | $86.40 | $418,608 | Direct |
1-10 of 15 transactions